Citadel Advisors’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.06M Buy
471,392
+304,638
+183% +$1.44M ﹤0.01% 6008
2025
Q4
$842K Buy
166,754
+84,450
+103% +$392K ﹤0.01% 7794
2025
Q3
$286K Sell
82,304
-534,781
-87% -$2.01M ﹤0.01% 10490
2025
Q2
$2.1M Buy
617,085
+14,568
+2% +$48.5K ﹤0.01% 5621
2025
Q1
$2.42M Buy
602,517
+401,377
+200% +$2.08M ﹤0.01% 5164
2024
Q4
$1.31M Sell
201,140
-69,432
-26% -$414K ﹤0.01% 6497
2024
Q3
$1.5M Buy
270,572
+213,444
+374% +$1.21M ﹤0.01% 6057
2024
Q2
$319K Buy
+57,128
New +$343K ﹤0.01% 9017
2023
Q4
Sell
-404
Closed -$2.23K 14394
2023
Q3
$2.23K Sell
404
-755
-65% -$6.06K ﹤0.01% 13745
2023
Q2
$9.9K Sell
1,159
-391,733
-100% -$3.51M ﹤0.01% 13233
2023
Q1
$3.61M Buy
392,892
+343,750
+700% +$3.7M ﹤0.01% 4350
2022
Q4
$502K Buy
+49,142
New +$660K ﹤0.01% 8225
2022
Q3
Sell
-264,928
Closed -$3.44M 12802
2022
Q2
$2.84M Buy
264,928
+239,579
+945% +$2.38M ﹤0.01% 4852
2022
Q1
$273K Sell
25,349
-67,020
-73% -$905K ﹤0.01% 10795
2021
Q4
$1.51M Buy
92,369
+77,051
+503% +$1.61M ﹤0.01% 6872
2021
Q3
$328K Buy
+15,318
New +$360K ﹤0.01% 10871

Other funds holding CTKB